Testosterone Effects on Brain Imaging and Headache in Transmasculine Youth
Studies changes in headache and brain scans in transmasculine youth starting testosterone.
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, United StatesSee the site
- Trial code
- Registry title
- Puberty, Testosterone, and Brain Development
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 31 Dec 2024
- Expected to end
- Jan 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Testosterone
- Record updated
- 21 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for transmasculine and gender diverse young people, assigned female at birth, who plan to start testosterone as part of their regular care within 6 months.
- Age
- 12 to 20 years old.
- Sex
- Assigned female at birth (transmasculine and gender diverse).
- Earlier treatment
- Plan to start testosterone clinically in less than 6 months. If taking a puberty blocker (GnRHa), it must have been started 3 or more months before joining.
Main reasons for not taking part
- Cognitive or psychiatric impairment that makes study procedures impossible
- History of stroke, multiple sclerosis or other serious neurologic condition
- Turner Syndrome or other difference of sexual development
- Polycystic ovarian syndrome (PCOS)
- Uncontrolled or untreated hypothyroidism
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- transmasculine and gender diverse
- assigned female at birth
- age 12-20 years at the time of enrollment
- plan to start testosterone clinically in < 6 months
- if taking gonadotropin releasing hormone agonist (GnRHa, puberty blocker), was started on this type of drug 3+ months prior to enrollment
Who cannot take part
- prior diagnosis of Turner Syndrome (monosomy X) or other difference of sexual development
- prior diagnosis of polycystic ovarian syndrome (PCOS)
- cognitive or psychiatric impairment resulting in inability to tolerate or perform the study procedures
- known history of stroke, multiple sclerosis, or other serious neurologic condition
- uncontrolled or untreated hypothyroidism
- MRI-specific exclusion criteria: (Weight > 500 lbs, severe claustrophobia, certain type of metal in body)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 20 years old?
Where in United States
- Children's Hospital ColoradoAurora, United StatesContact: Jennifer HranilovichTaking people
About the trial
What the trial wants to find out
Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may experience changes in headache. Researchers think this because studies published on effects of giving testosterone to cisgender females (female sex, female gender identity) and transmasculine adults seem to show an effect on pain.
Read full original descriptionShow less
This research will help us learn more about changes in headache and in brain structure and function in transmasculine youth during the first year of T. Youth who will be starting T within 6 months, either on puberty blocker or not, as part of their regular medical care can participate and will be asked to attend 3 visits:
* before starting T * after 6 months on T * after 1 year on T
At the visits, they will be asked to:
* answer questions and surveys about their health * have a brain MRI done * give a small sample of blood
and at their first visit, complete a physical exam. Some participants can also do a brief test of pain sensitivity. All participants will be asked to complete a headache diary for the first 6 months and for 1 month after the 1 year visit.
The 2 groups in the trial
- On blocker
Transmasculine youth who will begin taking testosterone clinically in \< 6 months with or without headache and who have been on pubertal blocker, a gonadotropin hormone releasing (GnRH) agonist for at least 3 months.
Treatment: Testosterone
- No blocker
Transmasculine youth who will begin taking testosterone clinically in \< 6 months with or without headache and who have no history of pubertal blocker.
Treatment: Testosterone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Testosterone on Brain Imaging and Headache in Transmasculine Adolescents
- Plain-language title
- Testosterone Effects on Brain Imaging and Headache in Transmasculine YouthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06670053, who can take part
- Record updated
- 21 September 2026